Establishment Labs reported a 11.3% increase in revenue to $41.4 million in Q1 2025 compared to the prior year, primarily driven by strong U.S. sales. Despite the revenue growth, the company experienced increased operating expenses, resulting in a higher net loss and adjusted EBITDA loss compared to Q1 2024. The cash balance at the end of the quarter was $69.2 million.
Worldwide revenue for Q1 2025 was $41.4 million, an increase from $37.2 million in Q1 2024.
Gross margin improved to 67.2% in Q1 2025 from 65.6% in the prior year period.
Net loss for Q1 2025 was $20.7 million, compared to a net loss of $16.2 million in Q1 2024.
Cash and cash equivalents stood at $69.2 million as of March 31, 2025.
Establishment Labs maintained its full-year 2025 revenue guidance and anticipates exceeding its previous U.S. revenue guidance. The company expects to achieve positive EBITDA in 2025 and positive cash flow in 2026.
Analyze how earnings announcements historically affect stock price performance